Connect with others who understand.

Sign up Log in
Resources
About myRAteam
Powered By
SPONSORED IN PART BY UCB, INC. ?

What Does Rheumatoid Factor Mean for Treating RA?

Medically reviewed by Baran Ufuktepe, M.D., Ph.D.
Posted on January 6, 2025


If you have rheumatoid arthritis (RA), you may have heard of something called rheumatoid factor (RF). Rheumatoid factor is a protein that might be found in the blood.1 Doctors check for rheumatoid factor to help figure out if someone has an autoimmune disease, such as rheumatoid arthritis or Sjӧgren’s syndrome.2 When rheumatoid factor is found, it can help doctors determine if you have RA.1 Higher levels of RF may provide further information on the long-term outcomes of your condition, as well as be a signal for your doctor to consider treatment differently.3-6

Some members of myRAteam have written about their rheumatoid factor test results. For example, a member asked, “Has the rheumatoid factor shown up in everyone’s blood testing?”

One member responded, “I have a high positive rheumatoid factor,” while a different member said, “The rheumatoid factor has not shown up in my blood work.”

Just because someone has a positive rheumatoid factor test, that doesn’t mean they have RA.2 However, around 80 percent of people with RA will have a positive rheumatoid factor test.7 If you have RA, keep reading to learn more about rheumatoid factor and what it could mean for treating your RA.8

1. Rheumatoid Factor May Help Decide Which RA Treatment You Should Try

Health care providers look at many different factors of RA and health when they’re trying to figure out the best treatment plan for a person’s RA. This is because different components of the disease can help doctors predict how a certain treatment may work.9,10

Around 80 percent of people with RA will have a positive rheumatoid factor test.7


When doctors are trying to figure out how to treat your RA, they may look at several details:

How active your RA is — Based on results of medical tests or by counting how many of your joints hurt or are swollen because of RA11
How high rheumatoid factor is in your blood — Doctors will see how high your disease markers, such as RF levels, are2,8
Whether you have bone erosion — Bone damage from RA11
Which joints RA affects10
How old you are10
How healthy you are overall and what other conditions you might have in addition to RA10,12

Your rheumatology doctor will think about these and other details when deciding on the best treatment plan for your RA. Considering these different factors will help your doctor know which type of treatment might work the best for you and which may not work as well.

2. Rheumatoid Factor May Help Decide When You Should Start an RA Treatment

Your doctor will decide when you should start RA treatment by considering different details about your RA. If you have high disease activity and high rheumatoid factor in your body, your doctor might recommend a more advanced treatment or that you start treatment more quickly.12

Doctors may look for other clues to figure out who needs what type of RA treatment or if they should start treatment sooner.12 They’ll see if you have:

  • Extra-articular disease — This means your RA is affecting parts of your body aside from your joints. If you have extra-articular disease, it could mean your RA is more severe.11,12
  • Functional limitation — This means your RA keeps you from moving normally because your joints are swollen or painful.12
  • Bone erosions — This means some of your bone has been damaged by RA.12


If you have high disease activity and high rheumatoid factor, your doctor might recommend a more advanced treatment or that you start treatment sooner.12


RA is a condition that can get worse as time goes on. It can harm your joints and change their shape, which can make it hard for you to move around. Beginning treatment early can help stop your symptoms from getting worse and make movement easier.10

3. Rheumatoid Factor May Help Predict How Well Your RA Treatment Will Work

The goals of treating RA are to help lower your pain and swelling and to stop the condition from getting worse. There are many treatment options for RA. When picking the best treatment for you, your doctor will think about your overall health and some specific factors about your RA, such as the severity, disease activity, and how long you’ve had symptoms or a diagnosis.9,10

Some studies have found that the presence or absence of rheumatoid factor, among other information about a person’s RA, may play a role in achieving remission with RA.13 For example, a study called “Diagnosis and Management of Rheumatoid Arthritis” looked at different details that can help predict if a treatment will help lessen someone’s RA symptoms.14

Some studies have found that the presence or absence of rheumatoid factor, among other information about a person’s RA, may play a role in achieving remission with RA.13


The study found that treatment reduced symptoms for some people with RA, but this improvement was more likely for certain people. People who had reduced symptoms were male, were younger than 40 years old, didn’t smoke, had less severe disease, and did not have positive rheumatoid factor, among other info about their RA.14

Rheumatoid factor, especially in higher levels, can be a sign that your RA is more severe, and it may affect how different treatments work for you.12,14

Doctors May Consider Rheumatoid Factor When Planning Your Advanced RA Treatment

Some researchers have found that certain drugs work differently if a person has both high levels of RF and high levels of anti-cyclic citrullinated peptide antibodies (called ACPA or anti-CCP).15 Anti-CCP is a protein that may be found in the blood of people with autoimmune conditions such as RA.14 High levels of anti-CCP and high levels of rheumatoid factor can help a doctor confirm a diagnosis of rheumatoid arthritis.14

For example, one study looked at people who have both high levels of rheumatoid factor and high levels of anti-CCP.15 The study results showed that both high levels of rheumatoid factor and high levels of anti-CCP matched up with amounts of a substance in the body called tumor necrosis factor (TNF), which makes swelling happen.15 Some RA medicines work by targeting TNF to lower swelling. The study suggested that doctors should think about both high levels of rheumatoid factor and high levels of anti-CCP when deciding if a TNF inhibitor is a good choice for RA treatment.15

Talk to Your Doctor

Rheumatoid factor is something that helps doctors figure out if you have RA. It can also help them know how advanced your RA might be, and it can help them make a treatment plan for your individual needs. If you have questions about rheumatoid factor and what it means for your RA, ask a health care professional or your rheumatologist.

References
  1. Dunkin MA. Testing for rheumatoid arthritis. Arthritis Foundation. June 12, 2022. Accessed December 5, 2024. https://www.arthritis.org/diseases/more-about/testing-for-rheumatoid-arthritis
  2. Rheumatoid factor (RF). Mount Sinai. Updated April 30, 2023. Accessed December 5, 2024. https://www.mountsinai.org/health-library/tests/rheumatoid-factor-rf
  3. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-2581. doi:10.1002/art.27584.
  4. Aletaha D, Alasti F, Smolen JS. Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity. Ann Rheum Dis. 2013;72(6):875-880. doi:10.1136/annrheumdis-2012-201517
  5. Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021;73(7):924-939. doi:10.1002/acr.24596
  6. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023-2038. doi:10.1016/S0140-6736(16)30173-8
  7. Rheumatoid arthritis. Cleveland Clinic. Updated November 6, 2024. Accessed December 5, 2024. https://my.clevelandclinic.org/health/diseases/4924-rheumatoid-arthritis
  8. Shmerling RH. Rheumatoid factor: biology and utility of measurement. Wolters Kluwer UpToDate. Updated July 19, 2023. Accessed December 5, 2024. https://www.uptodate.com/contents/rheumatoid-factor-biology-and-utility-of-measurement
  9. Mayo Clinic staff. Rheumatoid arthritis: diagnosis & treatment. Mayo Clinic. January 25, 2023. Accessed December 5, 2024. https://www.mayoclinic.org/diseases-conditions/rheumatoid-arthritis/diagnosis-treatment/drc-20353653
  10. Bullock J, Rizvi SAA, Saleh AM, et al. Rheumatoid arthritis: a brief overview of the treatment. Med Princ Pract. 2018;27(6):501-507. doi:10.1159/000493390
  11. Albrecht K, Zink A. Poor prognostic factors guiding treatment decisions in rheumatoid arthritis patients: a review of data from randomized clinical trials and cohort studies. Arthritis Res Ther. 2017;19(1):68. doi:10.1186/s13075-017-1266-4
  12. Moreland LW, Cannella A. General principles and overview of management of rheumatoid arthritis in adults. Wolters Kluwer UpToDate. Updated May 14, 2024. Accessed December 5, 2024. https://www.uptodate.com/contents/general-principles-and-overview-of-management-of-rheumatoid-arthritis-in-adults
  13. Katchamart W, Johnson S, Lin HJ, Phumethum V, Salliot C, Bombardier C. Predictors for remission in rheumatoid arthritis patients: a systematic review. Arthritis Care Res (Hoboken). 2010;62(8):1128-1143. doi:10.1002/acr.20188
  14. Wasserman A. Diagnosis and management of rheumatoid arthritis. Am Fam Physician. 2011;84(11):1245-1252. Accessed December 5, 2024. https://www.aafp.org/pubs/afp/issues/2011/1201/p1245.html
  15. Takeuchi T, Miyasaka N, Inui T, et al. High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study. Arthritis Res Ther. 2017;19(1):194. doi:10.1186/s13075-017-1401-2


GL-DA-2400559 © UCB Biopharma SRL, 2024. All rights reserved.
Date of preparation: December 2024

Baran Ufuktepe, M.D., Ph.D. is an M.D. with a Ph.D. in pharmacology. He has worked in Rheumatology Medical Affairs at UCB for over 10 years. Learn more about him here.
Elizabeth Wartella, M.P.H. is an Editor at MyHealthTeam. She holds a Master's in Public Health from Columbia University and is passionate about spreading accurate, evidence-based health information. Learn more about her here.
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy

Thank you for subscribing!

Become a member to get even more: